Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia
ConditionTrigeminal Neuralgia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospital Universitari de Bellvitge
About this trial
This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia
Eligibility criteria
Qualifiers
Diagnosis of classical or idiopathic trigeminal neuralgia according to the criteria of the International Classification of Headache Disorders (ICHD-3).
Age over 18 years.
Signed informed consent.
Disqualifiers
Contraindication for treatment with lacosamide (previous hypersensitivity reaction, known atrioventricular block).
Mental or psychiatric illness that interferes with the ability to understand and sign the informed consent.
Language barrier.
Lack of cooperation.
Trial design
Treatments tested in this trial
- Lacosamide
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov